Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Ozempic (semaglutide) remains stable for approximately 30 days after first injection when stored at 2–8°C, though unopened pens maintain efficacy until the printed expiration date. Storage temperature, pen handling, and individual metabolic factors all influence how long the medication delivers therapeutic benefit.

For patients considering GLP-1 treatment, understanding medication stability and duration of action is essential—but so is recognizing that response varies significantly between individuals. PlexusDx takes a precision-wellness approach: combining evidence-based storage guidance with insights into genetic factors that may influence how your body processes GLP-1 medications.

Storage Timeline: When Ozempic Remains Effective

Unopened Ozempic pens retain full potency until the printed expiration date when stored in a refrigerator at 2–8°C (35–46°F). Once a pen is first used, it should be discarded after 30 days, even if unused medication remains in the cartridge. Temperature stability is critical: exposure above 30°C or freezing conditions can degrade the active ingredient.

Room-temperature storage (up to 25°C/77°F) is acceptable for up to 30 days if refrigeration is unavailable, but the 30-day post-injection window still applies. Patients should never store Ozempic in the freezer or leave it unrefrigerated for extended periods. Proper storage practices directly affect medication potency and treatment outcomes.

Medication Stability and Duration: A Clinical Overview

GLP-1 receptor agonists like semaglutide have a half-life of approximately 7 days, meaning it takes roughly one week for the body to metabolize half the injected dose. Weekly dosing schedules capitalize on this pharmacokinetic profile, allowing steady-state drug levels and consistent appetite suppression throughout the week. Individual absorption rates vary based on injection site, body composition, and metabolic factors.

Storage Condition Duration of Effectiveness Clinical Consideration
Unopened, refrigerated (2–8°C) Until printed expiration date Optimal storage preserves full potency
Opened pen, refrigerated (2–8°C) 30 days maximum Discard after 30 days regardless of remaining dose
Room temperature (up to 25°C) 30 days maximum Use only if refrigeration unavailable; same 30-day discard rule applies
Frozen or heated (>30°C) Compromised effectiveness Medication degradation; do not use if exposed to extreme temperatures

How Individual Metabolism Affects GLP-1 Effectiveness Duration

Semaglutide's therapeutic window—the period during which appetite suppression and metabolic effects remain noticeable—varies between patients due to differences in GLP-1 receptor expression, insulin secretion patterns, and hepatic clearance rates. A weekly injection may sustain symptom control for 7 days in one patient but 5–6 days in another, influencing both efficacy and side-effect timing throughout the week.

Factors including age, body weight, concurrent medications, and liver function all modulate how quickly the body processes and eliminates semaglutide. Patients who experience waning appetite suppression before their next scheduled injection may benefit from dose adjustments—a decision best made with a qualified healthcare provider after documenting symptom patterns.

Genetic Predispositions and GLP-1 Response: Understanding Your Personal Risk Profile

Emerging research indicates that genetic variation in GLP-1 receptor function (GLP1R rs6923761), GIPR signaling (GIPR rs1800437), and appetite-regulation pathways (MC4R rs17782313, FTO rs9939609) may help provide context for how individual patients respond to and maintain benefit from GLP-1 medications. These predispositions do not determine exact medication response, but they can support a more informed conversation between patient and provider about treatment expectations and optimization.

The Precision Peptide Genetic Test examines these peptide pathway variants, revealing whether your genetic profile suggests heightened or reduced predisposition in GLP-1 sensitivity, glucose regulation, and appetite pathways. This information should be interpreted with a qualified healthcare provider and combined with clinical assessment, not viewed as a guaranteed predictor of medication success. Understanding your genetic context may help personalize dosing strategies, medication selection, and duration-of-action expectations.

How PlexusDx Supports a More Personalized Approach

PlexusDx's precision-wellness framework recognizes that 'how long Ozempic works' depends on three layers: pharmaceutical stability (storage and time), pharmacokinetics (half-life and clearance), and pharmacogenomics (genetic factors influencing receptor sensitivity and metabolic response). Combining these perspectives helps patients and providers move beyond one-size-fits-all dosing toward individualized, evidence-informed treatment.

The Precision Peptide Genetic Test reveals predispositions in GLP-1 receptor signaling and appetite-regulation pathways that may help explain why some patients sustain benefit throughout a 7-day interval while others experience waning effects. These variants—GLP1R rs6923761, GIPR rs1800437, MC4R rs17782313, and FTO rs9939609—provide biological context, not a diagnosis or guarantee of medication response. When interpreted by a qualified provider, this data can support more targeted treatment conversations.

Understanding your genetic predispositions alongside standard clinical markers can help guide conversations about medication selection, dosing frequency, and realistic expectations for duration of action. PlexusDx compounded GLP-1 options (semaglutide injection starting at $149/mo and tirzepatide injection starting at $249/mo) offer flexibility across dosing schedules, and paired with genetic insights, enable more personalized treatment planning.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves